LENZ
LENZ Therapeutics Inc.

1,263
Mkt Cap
$583.56M
Volume
1.28M
52W High
$50.40
52W Low
$14.43
PE Ratio
-8.44
LENZ Fundamentals
Price
$17.78
Prev Close
$18.65
Open
$18.65
50D MA
$21.29
Beta
1.36
Avg. Volume
1.15M
EPS (Annual)
-$2.34
P/B
2.62
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ...
PR Newswire·8d ago
News Placeholder
More News
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ...
PR Newswire·15d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Trading Up 9.5% - Should You Buy?
LENZ Therapeutics (NASDAQ:LENZ) Trading 9.5% Higher - What's Next...
MarketBeat·15d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ...
PR Newswire·22d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Hits New 1-Year Low - What's Next?
LENZ Therapeutics (NASDAQ:LENZ) Hits New 12-Month Low - What's Next...
MarketBeat·27d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ...
PR Newswire·29d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 5.1% - Time to Sell?
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 5.1% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Shares Up 5% - What's Next?
LENZ Therapeutics (NASDAQ:LENZ) Shares Up 5% - Time to Buy...
MarketBeat·1mo ago
News Placeholder
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Moderate Buy" by Analysts
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are presently covering the firm, MarketBeat reports...
MarketBeat·1mo ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Sees Large Volume Increase - Should You Buy?
LENZ Therapeutics (NASDAQ:LENZ) Sees Strong Trading Volume - Time to Buy...
MarketBeat·2mo ago
<
1
2
...
>

Latest LENZ News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.